Docket
117th Congress · HOUSE BILLBILL

H.R. 7529 — Plain Prescription Prices Act

“To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.”

Health
Introduced Apr 14, 2022
Last action Apr 15, 2022
Pipeline · Bill → Law
Step 1
Introduced
Apr 14, 2022
Step 2
Referred
Apr 15, 2022
E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 4 actions
Apr 15, 2022
Referred to the Subcommittee on Health.
Apr 14, 2022
Introduced in House
Apr 14, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 14, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.